These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27036008)

  • 21. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
    Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
    Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Green design "bioinspired disassembly-reassembly strategy" applied for improved tumor-targeted anticancer drug delivery.
    Wang R; Gu X; Zhou J; Shen L; Yin L; Hua P; Ding Y
    J Control Release; 2016 Aug; 235():134-146. PubMed ID: 27238442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reductively cleavable polymer-drug conjugates based on dendritic polyglycerol sulfate and monomethyl auristatin E as anticancer drugs.
    Rades N; Achazi K; Qiu M; Deng C; Haag R; Zhong Z; Licha K
    J Control Release; 2019 Apr; 300():13-21. PubMed ID: 30794827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
    Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
    J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI-visible liposome nanovehicles for potential tumor-targeted delivery of multimodal therapies.
    Ren L; Chen S; Li H; Zhang Z; Ye C; Liu M; Zhou X
    Nanoscale; 2015 Aug; 7(30):12843-50. PubMed ID: 26022345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dual modal imaging and chemotherapy of breast cancer.
    Abbasi AZ; Prasad P; Cai P; He C; Foltz WD; Amini MA; Gordijo CR; Rauth AM; Wu XY
    J Control Release; 2015 Jul; 209():186-96. PubMed ID: 25908171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
    He Y; Su Z; Xue L; Xu H; Zhang C
    J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
    Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
    Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shell-crosslinked hybrid nanoparticles for direct cytosolic delivery for tumor therapy.
    He W; Jin Z; Lv Y; Cao H; Yao J; Zhou J; Yin L
    Int J Pharm; 2015 Jan; 478(2):762-72. PubMed ID: 25529435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging.
    Schleich N; Sibret P; Danhier P; Ucakar B; Laurent S; Muller RN; Jérôme C; Gallez B; Préat V; Danhier F
    Int J Pharm; 2013 Apr; 447(1-2):94-101. PubMed ID: 23485340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protease-activatable cell-penetrating peptide possessing ROS-triggered phase transition for enhanced cancer therapy.
    Yoo J; Sanoj Rejinold N; Lee D; Jon S; Kim YC
    J Control Release; 2017 Oct; 264():89-101. PubMed ID: 28842316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer.
    Bai F; Wang C; Lu Q; Zhao M; Ban FQ; Yu DH; Guan YY; Luan X; Liu YR; Chen HZ; Fang C
    Biomaterials; 2013 Aug; 34(26):6163-74. PubMed ID: 23706689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel high drug loading mussel-inspired polydopamine hybrid nanoparticle as a pH-sensitive vehicle for drug delivery.
    Hou J; Guo C; Shi Y; Liu E; Dong W; Yu B; Liu S; Gong J
    Int J Pharm; 2017 Nov; 533(1):73-83. PubMed ID: 28943209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of octreotide surface density on receptor-mediated endocytosis in vitro and anticancer efficacy of modified nanocarrier in vivo after optimization.
    Su Z; Shi Y; Xiao Y; Sun M; Ping Q; Zong L; Li S; Niu J; Huang A; You W; Chen Y; Chen X; Fei J; Tian J
    Int J Pharm; 2013 Apr; 447(1-2):281-92. PubMed ID: 23396258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained release of PTX-incorporated nanoparticles synergized by burst release of DOX⋅HCl from thermosensitive modified PEG/PCL hydrogel to improve anti-tumor efficiency.
    Xu S; Wang W; Li X; Liu J; Dong A; Deng L
    Eur J Pharm Sci; 2014 Oct; 62():267-73. PubMed ID: 24931190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
    Yu DH; Lu Q; Xie J; Fang C; Chen HZ
    Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.
    Zhang X; Li F; Guo S; Chen X; Wang X; Li J; Gan Y
    Biomaterials; 2014 Apr; 35(11):3650-65. PubMed ID: 24462359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic delivery of a Gli inhibitor via polymeric nanocarriers inhibits tumor-induced bone disease.
    Vanderburgh JP; Kwakwa KA; Werfel TA; Merkel AR; Gupta MK; Johnson RW; Guelcher SA; Duvall CL; Rhoades JA
    J Control Release; 2019 Oct; 311-312():257-272. PubMed ID: 31494183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
    Hwang HY; Kim IS; Kwon IC; Kim YH
    J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model.
    Roy A; Singh MS; Upadhyay P; Bhaskar S
    Int J Pharm; 2013 Mar; 445(1-2):171-80. PubMed ID: 23376226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.